Variable | Adult cohort n = 106 | Pediatric cohort n = 19 | |
---|---|---|---|
Age at diagnosis (years) | Median | 54 | 8 |
Range | 21–93 | 2–17 | |
Sex | Female | 54 (51%) | 9 (47%) |
Male | 52 (49%) | 10 (53%) | |
Stage (TNM) | I | 7 (7%) | 4 (21%) |
II | 13 (12%) | - | |
III | 26 (25%) | - | |
IV | 56 (53%) | 6 (32%) | |
Other (Non-TNM) | - | 9 (47%) | |
Unknown | 4 (3%) | - | |
Prior lines of systemic therapies | 0–1 | 41 (38%) | 11 (58%) |
2–3 | 48 (45%) | 5 (26%) | |
4 or more | 18 (17%) | 3 (16%) | |
Prior standard-of-care targeted therapy | 11 (10%) | - |